290 related articles for article (PubMed ID: 28198371)
1. Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells.
Gong H; Liu M; Klomp J; Merrill BJ; Rehman J; Malik AB
Sci Rep; 2017 Feb; 7():42127. PubMed ID: 28198371
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
[TBL] [Abstract][Full Text] [Related]
4. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
[TBL] [Abstract][Full Text] [Related]
5. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
6. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
[TBL] [Abstract][Full Text] [Related]
7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
8. Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line.
Dehler CE; Boudinot P; Martin SA; Collet B
Mar Biotechnol (NY); 2016 Aug; 18(4):449-52. PubMed ID: 27236514
[TBL] [Abstract][Full Text] [Related]
9. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
Suresh B; Ramakrishna S; Kim H
Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
[TBL] [Abstract][Full Text] [Related]
10. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
12. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
13. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
Sandoval IM; Collier TJ; Manfredsson FP
Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing.
Ma Y; Yu L; Pan S; Gao S; Chen W; Zhang X; Dong W; Li J; Zhou R; Huang L; Han Y; Bai L; Zhang L; Zhang L
FEBS J; 2017 Oct; 284(19):3262-3277. PubMed ID: 28763160
[TBL] [Abstract][Full Text] [Related]
15. Conditional Control of CRISPR/Cas9 Function.
Zhou W; Deiters A
Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
[TBL] [Abstract][Full Text] [Related]
16. Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver.
Tsukamoto T; Sakai E; Iizuka S; Taracena-Gándara M; Sakurai F; Mizuguchi H
Biol Pharm Bull; 2018; 41(7):1089-1095. PubMed ID: 29962404
[TBL] [Abstract][Full Text] [Related]
17. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
19. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]